Author:
Aggarwal Dinesh,Kanitkar Tanmay,Narouz Michael,Azadian Berge S.,Moore Luke S. P.,Mughal Nabeela
Abstract
Abstract16S ribosomal-ribonucleic acid polymerase chain reaction (PCR) and targeted PCR aid microbiological diagnosis in culture-negative clinical samples. Despite routine clinical use, there remains a paucity of data on their effectiveness across a variety of clinical sample types, and cost-effectiveness. In this 4 year multicentre retrospective observational study, all clinical samples referred for 16S PCR and/or targeted PCR from a laboratory network serving seven London hospitals were identified. Laboratory, clinical, prescribing, and economic variables were analysed. 78/607 samples were 16S PCR positive; pus samples were most frequently positive (29/84; p < 0.0001), and CSF least (8/149; p = 0.003). 210/607 samples had targeted PCR (361 targets requested across 23 organisms) with 43/361 positive; respiratory samples (13/37; p = 0.01) had the highest detection rate. Molecular diagnostics provided a supportive microbiological diagnosis for 21 patients and a new diagnosis for 58. 14/91 patients with prescribing information available and a positive PCR result had antimicrobial de-escalation. For culture-negative samples, mean cost-per-positive 16S PCR result was £568.37 and £292.84 for targeted PCR, equating to £4041.76 and £1506.03 respectively for one prescription change. 16S PCR is more expensive than targeted PCR, with both assisting in microbiological diagnosis but uncommonly enabling antimicrobial change. Rigorous referral pathways for molecular tests may result in significant fiscal savings.
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Valones, M. A. et al. Principles and applications of polymerase chain reaction in medical diagnostic fields: a review. Braz. J. Microbiol. 40, 1–11 (2009).
2. Pernica, J. M., Moldovan, I., Chan, F. & Slinger, R. Real-time polymerase chain reaction for microbiological diagnosis of parapneumonic effusions in Canadian children. Can. J. Infect. Dis. Med. Microbiol. 25(3), 151–154 (2014).
3. Hett, E. C. & Rubin, E. J. Bacterial growth and cell division: a mycobacterial perspective. Microbiol. Mol. Biol. Rev. 72, 126–156 (2008).
4. UK Standards for Microbiology Investigations: Introduction to the preliminary identification of medically important bacteria and fungi from culture (SMI ID1i2: updated April 2017, Public Health England). Available at: https://www.gov.uk/government/publications/smi-id-1-preliminary-identification-of-medically-important-bacteria. Accessed 03 October 2019.
5. Harris, K. A. & Hartley, J. C. Development of broad-range 16S rDNA PCR for use in the routine diagnostic clinical microbiology service. J. Med. Microbiol. 52, 685–691 (2003).
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献